Urokinase Injection Market, Global Outlook and Forecast 2022-2028

July 2024 | 74 pages | ID: U7EEE93CA0C6EN
Market Monitor Global

Abstracts

Urokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and other animals. The human urokinase protein was discovered, but not named, by McFarlane and Pilling in 1947. Urokinase was originally isolated from human urine, and it is also present in the blood and in the extracellular matrix of many tissues. The primary physiological substrate of this enzyme is plasminogen, which is an inactive form (zymogen) of the serine protease plasmin.

This report contains market size and forecasts of Urokinase Injection in global, including the following market information:

Global Urokinase Injection Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Urokinase Injection Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Urokinase Injection companies in 2021 (%)

The global Urokinase Injection market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

10000-100000IU Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Urokinase Injection include NDPHARM, Wanhua Biochem, Jiangxi Haoran Bio-Pharma, Jiangsu Aidea Pharmaceutical, Techpool, Microbic Biosystems Inc and LIVZON, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Urokinase Injection manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Urokinase Injection Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Urokinase Injection Market Segment Percentages, by Type, 2021 (%)

• 10000-100000IU
• 100000-1000000IU
• Others

Global Urokinase Injection Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Urokinase Injection Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Clinic
• Others

Global Urokinase Injection Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Urokinase Injection Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Urokinase Injection revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Urokinase Injection revenues share in global market, 2021 (%)

Key companies Urokinase Injection sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Urokinase Injection sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• NDPHARM
• Wanhua Biochem
• Jiangxi Haoran Bio-Pharma
• Jiangsu Aidea Pharmaceutical
• Techpool
• Microbic Biosystems Inc
• LIVZON

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Urokinase Injection Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Urokinase Injection Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL UROKINASE INJECTION OVERALL MARKET SIZE

2.1 Global Urokinase Injection Market Size: 2021 VS 2028
2.2 Global Urokinase Injection Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Urokinase Injection Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Urokinase Injection Players in Global Market
3.2 Top Global Urokinase Injection Companies Ranked by Revenue
3.3 Global Urokinase Injection Revenue by Companies
3.4 Global Urokinase Injection Sales by Companies
3.5 Global Urokinase Injection Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Urokinase Injection Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Urokinase Injection Product Type
3.8 Tier 1, Tier 2 and Tier 3 Urokinase Injection Players in Global Market
  3.8.1 List of Global Tier 1 Urokinase Injection Companies
  3.8.2 List of Global Tier 2 and Tier 3 Urokinase Injection Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Urokinase Injection Market Size Markets, 2021 & 2028
  4.1.2 10000-100000IU
  4.1.3 100000-1000000IU
  4.1.4 Others
4.2 By Type - Global Urokinase Injection Revenue & Forecasts
  4.2.1 By Type - Global Urokinase Injection Revenue, 2017-2022
  4.2.2 By Type - Global Urokinase Injection Revenue, 2023-2028
  4.2.3 By Type - Global Urokinase Injection Revenue Market Share, 2017-2028
4.3 By Type - Global Urokinase Injection Sales & Forecasts
  4.3.1 By Type - Global Urokinase Injection Sales, 2017-2022
  4.3.2 By Type - Global Urokinase Injection Sales, 2023-2028
  4.3.3 By Type - Global Urokinase Injection Sales Market Share, 2017-2028
4.4 By Type - Global Urokinase Injection Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Urokinase Injection Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Clinic
  5.1.4 Others
5.2 By Application - Global Urokinase Injection Revenue & Forecasts
  5.2.1 By Application - Global Urokinase Injection Revenue, 2017-2022
  5.2.2 By Application - Global Urokinase Injection Revenue, 2023-2028
  5.2.3 By Application - Global Urokinase Injection Revenue Market Share, 2017-2028
5.3 By Application - Global Urokinase Injection Sales & Forecasts
  5.3.1 By Application - Global Urokinase Injection Sales, 2017-2022
  5.3.2 By Application - Global Urokinase Injection Sales, 2023-2028
  5.3.3 By Application - Global Urokinase Injection Sales Market Share, 2017-2028
5.4 By Application - Global Urokinase Injection Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Urokinase Injection Market Size, 2021 & 2028
6.2 By Region - Global Urokinase Injection Revenue & Forecasts
  6.2.1 By Region - Global Urokinase Injection Revenue, 2017-2022
  6.2.2 By Region - Global Urokinase Injection Revenue, 2023-2028
  6.2.3 By Region - Global Urokinase Injection Revenue Market Share, 2017-2028
6.3 By Region - Global Urokinase Injection Sales & Forecasts
  6.3.1 By Region - Global Urokinase Injection Sales, 2017-2022
  6.3.2 By Region - Global Urokinase Injection Sales, 2023-2028
  6.3.3 By Region - Global Urokinase Injection Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Urokinase Injection Revenue, 2017-2028
  6.4.2 By Country - North America Urokinase Injection Sales, 2017-2028
  6.4.3 US Urokinase Injection Market Size, 2017-2028
  6.4.4 Canada Urokinase Injection Market Size, 2017-2028
  6.4.5 Mexico Urokinase Injection Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Urokinase Injection Revenue, 2017-2028
  6.5.2 By Country - Europe Urokinase Injection Sales, 2017-2028
  6.5.3 Germany Urokinase Injection Market Size, 2017-2028
  6.5.4 France Urokinase Injection Market Size, 2017-2028
  6.5.5 U.K. Urokinase Injection Market Size, 2017-2028
  6.5.6 Italy Urokinase Injection Market Size, 2017-2028
  6.5.7 Russia Urokinase Injection Market Size, 2017-2028
  6.5.8 Nordic Countries Urokinase Injection Market Size, 2017-2028
  6.5.9 Benelux Urokinase Injection Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Urokinase Injection Revenue, 2017-2028
  6.6.2 By Region - Asia Urokinase Injection Sales, 2017-2028
  6.6.3 China Urokinase Injection Market Size, 2017-2028
  6.6.4 Japan Urokinase Injection Market Size, 2017-2028
  6.6.5 South Korea Urokinase Injection Market Size, 2017-2028
  6.6.6 Southeast Asia Urokinase Injection Market Size, 2017-2028
  6.6.7 India Urokinase Injection Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Urokinase Injection Revenue, 2017-2028
  6.7.2 By Country - South America Urokinase Injection Sales, 2017-2028
  6.7.3 Brazil Urokinase Injection Market Size, 2017-2028
  6.7.4 Argentina Urokinase Injection Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Urokinase Injection Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Urokinase Injection Sales, 2017-2028
  6.8.3 Turkey Urokinase Injection Market Size, 2017-2028
  6.8.4 Israel Urokinase Injection Market Size, 2017-2028
  6.8.5 Saudi Arabia Urokinase Injection Market Size, 2017-2028
  6.8.6 UAE Urokinase Injection Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 NDPHARM
  7.1.1 NDPHARM Corporate Summary
  7.1.2 NDPHARM Business Overview
  7.1.3 NDPHARM Urokinase Injection Major Product Offerings
  7.1.4 NDPHARM Urokinase Injection Sales and Revenue in Global (2017-2022)
  7.1.5 NDPHARM Key News
7.2 Wanhua Biochem
  7.2.1 Wanhua Biochem Corporate Summary
  7.2.2 Wanhua Biochem Business Overview
  7.2.3 Wanhua Biochem Urokinase Injection Major Product Offerings
  7.2.4 Wanhua Biochem Urokinase Injection Sales and Revenue in Global (2017-2022)
  7.2.5 Wanhua Biochem Key News
7.3 Jiangxi Haoran Bio-Pharma
  7.3.1 Jiangxi Haoran Bio-Pharma Corporate Summary
  7.3.2 Jiangxi Haoran Bio-Pharma Business Overview
  7.3.3 Jiangxi Haoran Bio-Pharma Urokinase Injection Major Product Offerings
  7.3.4 Jiangxi Haoran Bio-Pharma Urokinase Injection Sales and Revenue in Global (2017-2022)
  7.3.5 Jiangxi Haoran Bio-Pharma Key News
7.4 Jiangsu Aidea Pharmaceutical
  7.4.1 Jiangsu Aidea Pharmaceutical Corporate Summary
  7.4.2 Jiangsu Aidea Pharmaceutical Business Overview
  7.4.3 Jiangsu Aidea Pharmaceutical Urokinase Injection Major Product Offerings
  7.4.4 Jiangsu Aidea Pharmaceutical Urokinase Injection Sales and Revenue in Global (2017-2022)
  7.4.5 Jiangsu Aidea Pharmaceutical Key News
7.5 Techpool
  7.5.1 Techpool Corporate Summary
  7.5.2 Techpool Business Overview
  7.5.3 Techpool Urokinase Injection Major Product Offerings
  7.5.4 Techpool Urokinase Injection Sales and Revenue in Global (2017-2022)
  7.5.5 Techpool Key News
7.6 Microbic Biosystems Inc
  7.6.1 Microbic Biosystems Inc Corporate Summary
  7.6.2 Microbic Biosystems Inc Business Overview
  7.6.3 Microbic Biosystems Inc Urokinase Injection Major Product Offerings
  7.6.4 Microbic Biosystems Inc Urokinase Injection Sales and Revenue in Global (2017-2022)
  7.6.5 Microbic Biosystems Inc Key News
7.7 LIVZON
  7.7.1 LIVZON Corporate Summary
  7.7.2 LIVZON Business Overview
  7.7.3 LIVZON Urokinase Injection Major Product Offerings
  7.7.4 LIVZON Urokinase Injection Sales and Revenue in Global (2017-2022)
  7.7.5 LIVZON Key News

8 GLOBAL UROKINASE INJECTION PRODUCTION CAPACITY, ANALYSIS

8.1 Global Urokinase Injection Production Capacity, 2017-2028
8.2 Urokinase Injection Production Capacity of Key Manufacturers in Global Market
8.3 Global Urokinase Injection Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 UROKINASE INJECTION SUPPLY CHAIN ANALYSIS

10.1 Urokinase Injection Industry Value Chain
10.2 Urokinase Injection Upstream Market
10.3 Urokinase Injection Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Urokinase Injection Distributors and Sales Agents in Global

11 CONCLUSION


12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Urokinase Injection in Global Market
Table 2. Top Urokinase Injection Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Urokinase Injection Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Urokinase Injection Revenue Share by Companies, 2017-2022
Table 5. Global Urokinase Injection Sales by Companies, (K Units), 2017-2022
Table 6. Global Urokinase Injection Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Urokinase Injection Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Urokinase Injection Product Type
Table 9. List of Global Tier 1 Urokinase Injection Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Urokinase Injection Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Urokinase Injection Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Urokinase Injection Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Urokinase Injection Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Urokinase Injection Sales (K Units), 2017-2022
Table 15. By Type - Global Urokinase Injection Sales (K Units), 2023-2028
Table 16. By Application – Global Urokinase Injection Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Urokinase Injection Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Urokinase Injection Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Urokinase Injection Sales (K Units), 2017-2022
Table 20. By Application - Global Urokinase Injection Sales (K Units), 2023-2028
Table 21. By Region – Global Urokinase Injection Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Urokinase Injection Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Urokinase Injection Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Urokinase Injection Sales (K Units), 2017-2022
Table 25. By Region - Global Urokinase Injection Sales (K Units), 2023-2028
Table 26. By Country - North America Urokinase Injection Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Urokinase Injection Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Urokinase Injection Sales, (K Units), 2017-2022
Table 29. By Country - North America Urokinase Injection Sales, (K Units), 2023-2028
Table 30. By Country - Europe Urokinase Injection Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Urokinase Injection Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Urokinase Injection Sales, (K Units), 2017-2022
Table 33. By Country - Europe Urokinase Injection Sales, (K Units), 2023-2028
Table 34. By Region - Asia Urokinase Injection Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Urokinase Injection Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Urokinase Injection Sales, (K Units), 2017-2022
Table 37. By Region - Asia Urokinase Injection Sales, (K Units), 2023-2028
Table 38. By Country - South America Urokinase Injection Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Urokinase Injection Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Urokinase Injection Sales, (K Units), 2017-2022
Table 41. By Country - South America Urokinase Injection Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Urokinase Injection Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Urokinase Injection Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Urokinase Injection Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Urokinase Injection Sales, (K Units), 2023-2028
Table 46. NDPHARM Corporate Summary
Table 47. NDPHARM Urokinase Injection Product Offerings
Table 48. NDPHARM Urokinase Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Wanhua Biochem Corporate Summary
Table 50. Wanhua Biochem Urokinase Injection Product Offerings
Table 51. Wanhua Biochem Urokinase Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Jiangxi Haoran Bio-Pharma Corporate Summary
Table 53. Jiangxi Haoran Bio-Pharma Urokinase Injection Product Offerings
Table 54. Jiangxi Haoran Bio-Pharma Urokinase Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Jiangsu Aidea Pharmaceutical Corporate Summary
Table 56. Jiangsu Aidea Pharmaceutical Urokinase Injection Product Offerings
Table 57. Jiangsu Aidea Pharmaceutical Urokinase Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Techpool Corporate Summary
Table 59. Techpool Urokinase Injection Product Offerings
Table 60. Techpool Urokinase Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Microbic Biosystems Inc Corporate Summary
Table 62. Microbic Biosystems Inc Urokinase Injection Product Offerings
Table 63. Microbic Biosystems Inc Urokinase Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. LIVZON Corporate Summary
Table 65. LIVZON Urokinase Injection Product Offerings
Table 66. LIVZON Urokinase Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. Urokinase Injection Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 68. Global Urokinase Injection Capacity Market Share of Key Manufacturers, 2020-2022
Table 69. Global Urokinase Injection Production by Region, 2017-2022 (K Units)
Table 70. Global Urokinase Injection Production by Region, 2023-2028 (K Units)
Table 71. Urokinase Injection Market Opportunities & Trends in Global Market
Table 72. Urokinase Injection Market Drivers in Global Market
Table 73. Urokinase Injection Market Restraints in Global Market
Table 74. Urokinase Injection Raw Materials
Table 75. Urokinase Injection Raw Materials Suppliers in Global Market
Table 76. Typical Urokinase Injection Downstream
Table 77. Urokinase Injection Downstream Clients in Global Market
Table 78. Urokinase Injection Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. Urokinase Injection Segment by Type
Figure 2. Urokinase Injection Segment by Application
Figure 3. Global Urokinase Injection Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Urokinase Injection Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Urokinase Injection Revenue, 2017-2028 (US$, Mn)
Figure 7. Urokinase Injection Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Urokinase Injection Revenue in 2021
Figure 9. By Type - Global Urokinase Injection Sales Market Share, 2017-2028
Figure 10. By Type - Global Urokinase Injection Revenue Market Share, 2017-2028
Figure 11. By Type - Global Urokinase Injection Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Urokinase Injection Sales Market Share, 2017-2028
Figure 13. By Application - Global Urokinase Injection Revenue Market Share, 2017-2028
Figure 14. By Application - Global Urokinase Injection Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Urokinase Injection Sales Market Share, 2017-2028
Figure 16. By Region - Global Urokinase Injection Revenue Market Share, 2017-2028
Figure 17. By Country - North America Urokinase Injection Revenue Market Share, 2017-2028
Figure 18. By Country - North America Urokinase Injection Sales Market Share, 2017-2028
Figure 19. US Urokinase Injection Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Urokinase Injection Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Urokinase Injection Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Urokinase Injection Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Urokinase Injection Sales Market Share, 2017-2028
Figure 24. Germany Urokinase Injection Revenue, (US$, Mn), 2017-2028
Figure 25. France Urokinase Injection Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Urokinase Injection Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Urokinase Injection Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Urokinase Injection Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Urokinase Injection Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Urokinase Injection Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Urokinase Injection Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Urokinase Injection Sales Market Share, 2017-2028
Figure 33. China Urokinase Injection Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Urokinase Injection Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Urokinase Injection Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Urokinase Injection Revenue, (US$, Mn), 2017-2028
Figure 37. India Urokinase Injection Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Urokinase Injection Revenue Market Share, 2017-2028
Figure 39. By Country - South America Urokinase Injection Sales Market Share, 2017-2028
Figure 40. Brazil Urokinase Injection Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Urokinase Injection Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Urokinase Injection Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Urokinase Injection Sales Market Share, 2017-2028
Figure 44. Turkey Urokinase Injection Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Urokinase Injection Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Urokinase Injection Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Urokinase Injection Revenue, (US$, Mn), 2017-2028
Figure 48. Global Urokinase Injection Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Urokinase Injection by Region, 2021 VS 2028
Figure 50. Urokinase Injection Industry Value Chain
Figure 51. Marketing Channels